Boston Partners lowered its holdings in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 8.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,064,662 shares of the company’s stock after selling 368,698 shares during the quarter. Tenet Healthcare accounts for about 0.9% of Boston Partners’ holdings, making the stock its 24th biggest position. Boston Partners owned about 5.11% of Tenet Healthcare worth $1,039,038,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of THC. Manning & Napier Advisors LLC purchased a new position in Tenet Healthcare during the 2nd quarter valued at about $168,761,000. Aberdeen Group plc grew its position in shares of Tenet Healthcare by 4,392.9% in the third quarter. Aberdeen Group plc now owns 845,555 shares of the company’s stock valued at $216,090,000 after purchasing an additional 826,735 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $106,342,000. Arrowstreet Capital Limited Partnership increased its position in Tenet Healthcare by 57.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after purchasing an additional 244,901 shares during the last quarter. Finally, Voya Investment Management LLC increased its holdings in shares of Tenet Healthcare by 346.2% during the 3rd quarter. Voya Investment Management LLC now owns 162,756 shares of the company’s stock worth $41,594,000 after buying an additional 126,283 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.
Analyst Upgrades and Downgrades
THC has been the topic of several research reports. Barclays raised their price objective on Tenet Healthcare from $271.00 to $297.00 and gave the company an “overweight” rating in a research report on Wednesday, November 4th. Robert W. Baird upped their price target on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. KeyCorp increased their target price on Tenet Healthcare from $270.00 to $300.00 and gave the stock an “overweight” rating in a report on Tuesday, November 3rd. UBS Group raised their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Finally, Leerink Partners boosted their price objective on Tenet Healthcare from $309.00 to $342.00 and gave the company an “outperform” rating in a research report on Monday, November 2nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $296.65.
View Our Latest Stock Analysis on THC
Tenet Healthcare Stock Performance
THC opened at $271.54 on Thursday. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 1.76. The business’s 50 day moving average is $268.85 and its 200-day moving average is $226.26. The stock has a market cap of $21.61 billion, a PE ratio of 7.88, a price-to-earnings-growth ratio of 1.51 and a beta of 1.20. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $301.44.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The business had revenue of $6.28 billion during the quarter, compared to analyst estimates of $5.49 billion. During the same period in the prior year, the company posted $3.70 EPS. The business’s revenue for the quarter was up 6.5% compared to the same quarter last year. On average, analysts predict that Tenet Healthcare Corporation will post 22.32 earnings per share for the current year.
Insider Buying and Selling
In other news, Director Richard Mark sold 10,000 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the transaction, the director owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Cecil Haney sold 1,300 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.03, for a total value of $361,439.00. Following the transaction, the director directly owned 12,553 shares in the company, valued at $3,490,110.59. This trade represents a 9.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 99,462 shares of company stock valued at $27,081,234. Company insiders own 0.97% of the company’s stock.
Tenet Healthcare Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Read More
- Five stocks we like better than Tenet Healthcare
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
